Emergent BioSolutions Inc. — Form D

Emergent BioSolutions Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-30. The offering totals $47.9M, of which $47.9M was reported sold. Industry: Biotechnology.

Offering

Filed: 2018-10-30
Form: D
Accession: 0001567619-18-004769
Industry: Biotechnology
Exemptions: 06b
Total offering: $47.9M
Amount sold: $47.9M
Investors: 8
Date of first sale: 2018-10-15
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-324664

Issuer

Name: Emergent BioSolutions Inc.
CIK: 0001367644
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 400 PROFESSIONAL DR, SUITE 400, GAITHERSBURG, MD, 20879
Phone: 240-631-3200

Officers, directors & promoters (16)

Name	Role	Location
Daniel J Abdun-Nabi	Director	Gaithersburg, MD
Sue J Bailey	Director	Gaithersburg, MD
Fuad El-Hibri	Director	Gaithersburg, MD
Zsolt J Harsanyi	Director	Gaithersburg, MD
Jerome M Hauer	Director	Gaithersburg, MD
George J Joulwan	Director	Gaithersburg, MD
Ronald B Richard	Director	Gaithersburg, MD
Louis W Sullivan	Director	Gaithersburg, MD
Kathryn C Zoon	Director	Gaithersburg, MD
Daniel J Abdun-Nabi	Executive Officer	Gaithersburg, MD
Fuad El-Hibri	Executive Officer	Gaithersburg, MD
Adam R Havey	Executive Officer	Gaithersburg, MD
Robert G Kramer	Executive Officer	Gaithersburg, MD
Richard S Lindahl	Executive Officer	Gaithersburg, MD
Atul R Saran	Executive Officer	Gaithersburg, MD
Katherine R Strei	Executive Officer	Gaithersburg, MD

More